Treatment Guidelines

Cardiology Month in Review: May 2022

May 28, 2022

Our cardiology month in review spotlights the most popular content from the past month. This month's top articles include news from DELIVER, new guidelines for ICH and PFO, and a juxtaposition of international heart failure guidelines.

Don't Miss a Beat: Interpreting New Heart Failure Guidelines

May 04, 2022

In this episode of Don't Miss a Beat, hosts Drs. Greene and Vaduganathan break down the new ACC/AHA/HFSA heart failure guidelines debuted at ACC.22 and compare the recommendations against those made in the European Society of Cardiology's 2021 heart failure guidelines.

USPSTF Releases Updated Recommendations on Aspirin Use for Primary Prevention of Cardiovascular Disease

April 26, 2022

Published in JAMA on April 26, the latest recommendation statement from the USPSTF gives a grade C recommendation for use of low-dose aspirin for primary prevention of cardiovascular disease in adults aged 40-59 years who have a 10% or greater 10-year cardiovascular disease risk, concluding it could provide a small net benefit in these patients.

AHA Calls Attention to Growing Impact of NAFLD on Cardiovascular Disease Risk

April 14, 2022

The latest scientific statement from the American Heart Association is aimed at improving the awareness of NAFLD and its associated cardiovascular risk among clinicians as well as optimizing diagnosis and early treatment strategies for patients with NAFLD.

New Kawasaki Disease Guidelines Released by ACR, Vasculitis Foundation

March 11, 2022

On March 8, the American College of Rheumatology and the Vasculitis Foundation released new guidance for diagnosis and management of Kawasaki disease, which serves as the final companion piece to a trio of other ACR/VF vasculitis guidelines released in July 2021.

SCAI Releases New Statement on Sex-Based Considerations in Myocardial Revascularization

February 04, 2022

Released on February 4, the latest expert consensus statement from the Society for Cardiovascular Angiography and Interventions provides clinicians with an overview of available knowledge related to myocardial revascularization in women and calls attention to existing gaps in knowledge.